Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Anne McGeorge

Anne McGeorge is recorded as Chairman at Starling Oncology, Inc. (STLN) and Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH). Starling Oncology, Inc. reported in an 8-K filed August 13, 2025 that Anne McGeorge was appointed Chair of the Board. Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 12, 2023 that Anne McGeorge was appointed Board of Directors, effective September 11, 2023.

“Anne McGeorge will replace Mr. Barasch as Chair of the Board.”
Starling Oncology, Inc. Form 8-K, filed August 13, 2025 · Read the filing
“In accordance with the Merger Agreement, immediately after the closing of the Merger on September 11, 2023, the size of the Board of Directors was fixed at eight members, consisting of two members designated by the Company, who are Alison F. Lawton and Anne McGeorge, and six members designated by OpCo, who are Marino Garcia, Leon O. Moulder, Jr., Tomas Kiselak, Lei Meng, Paula Soteropoulos and Jonathan Violin, Ph.D.”
Dianthus Therapeutics, Inc. /DE/ Form 8-K, filed September 12, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Dianthus Therapeutics, Inc. /DE/

Other people whose current roles at this company are on record from its filings.

Leadership on record at Starling Oncology, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.